Feb 06, 2024 / 06:00AM GMT
Presentation
Feb 06, 2024 / 06:00AM GMT
=====================
Corporate Participants
=====================
* Keisuke Naito
Eisai Co., Ltd. - SVP, Chief Strategy, Planning & Ecosystem Officer and Acting Global Alzheimer's Disease Officer
* Lynn D. Kramer
Eisai Co., Ltd. - VP & Chief Clinical Officer - Alzheimer's Disease and Brain Health
* Mitsuru Shomon
Eisai Co., Ltd. - VP & CFO
* Takashi Owa
Eisai Co., Ltd. - Senior VP & Chief Scientific Officer - Japan and Asia Medical Safety
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
UBS Investment Bank, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
======
Eisai Co Ltd
(OTCPK:ESAIY)
$
8.14
0.01 (0.12%)
Market Cap: 9.17 Bil
Enterprise Value: 8.76 Bil
PE Ratio: 33.71
PB Ratio: 1.74
GF Score: 70/100 Q3 2024 Eisai Co Ltd Earnings Presentation Transcript
Feb 06, 2024 / 06:00AM GMT
Release Date Price:
$10.9
(-5.05%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot